Trial Profile
Drug Interactions Between Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Ombitasvir/paritaprevir/ritonavir (Primary) ; Glycyrrhizin; Ursodeoxycholic acid
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors AbbVie
- 04 Nov 2015 New trial record
- 23 Oct 2015 Results published in Clinical Therapeutics.